These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16137394)

  • 1. The significance of different formulations of aerosolized colistin.
    Michalopoulos A; Kasiakou SK; Falagas ME
    Crit Care; 2005 Aug; 9(4):417-8; author reply 417-8. PubMed ID: 16137394
    [No Abstract]   [Full Text] [Related]  

  • 2. A closer look at aerosolized colistin.
    van Leeuwen DH
    Clin Infect Dis; 2011 Jun; 52(12):1472-3; author reply 1473-4. PubMed ID: 21628491
    [No Abstract]   [Full Text] [Related]  

  • 3. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
    Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
    Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME
    Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
    Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
    Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-resistant Gram-negative infections: the use of colistin.
    Michalopoulos AS; Karatza DC
    Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1009-17. PubMed ID: 20818945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous and inhalational colistin-induced respiratory failure.
    Wahby K; Chopra T; Chandrasekar P
    Clin Infect Dis; 2010 Mar; 50(6):e38-40. PubMed ID: 20146630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii pneumonia.
    Falagas ME; Kasiakou SK; Michalopoulos A
    J Cyst Fibros; 2005 May; 4(2):149-50. PubMed ID: 15886070
    [No Abstract]   [Full Text] [Related]  

  • 9. Monotherapy with inhaled colistin for the treatment of patients with ventilator-associated tracheobronchitis due to polymyxin-only-susceptible Gram-negative bacteria.
    Athanassa ZE; Myrianthefs PM; Boutzouka EG; Tsakris A; Baltopoulos GJ
    J Hosp Infect; 2011 Aug; 78(4):335-6. PubMed ID: 21641678
    [No Abstract]   [Full Text] [Related]  

  • 10. [Shedding light on the use of colistin: still gaps to be filled].
    Luque S; Grau S; Berenguer N; Horcajada JP; Sorlí L; Montero MM; Salas E
    Enferm Infecc Microbiol Clin; 2011 Apr; 29(4):287-96. PubMed ID: 21440335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difficult-to-treat Gram-negative bone and joint infections: efficacy and safety of prolonged intravenous colistin.
    Valour F; Dutronc H; Dinh A; Cazorla C; Pavèse P; Lesens O; Uçkay I; Chidiac C; Ferry T;
    Int J Antimicrob Agents; 2013 Feb; 41(2):197-9. PubMed ID: 23146203
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous colistimethate for multidrug-resistant Gram-negative bacteria.
    Zavascki AP; Li J
    Lancet Infect Dis; 2008 Jul; 8(7):403-5. PubMed ID: 18582831
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous colistin administration in neonates.
    Jajoo M; Kumar V; Jain M; Kumari S; Manchanda V
    Pediatr Infect Dis J; 2011 Mar; 30(3):218-21. PubMed ID: 21245777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colistin pharmacokinetics: the fog is lifting.
    Couet W; Grégoire N; Marchand S; Mimoz O
    Clin Microbiol Infect; 2012 Jan; 18(1):30-9. PubMed ID: 21988234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections.
    Cheng CY; Sheng WH; Wang JT; Chen YC; Chang SC
    Int J Antimicrob Agents; 2010 Mar; 35(3):297-300. PubMed ID: 20045293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
    Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
    J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections.
    Falagas ME; Rafailidis PI; Kasiakou SK; Hatzopoulou P; Michalopoulos A
    Clin Microbiol Infect; 2006 Dec; 12(12):1227-30. PubMed ID: 17121631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii.
    Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T
    Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Returning to the pre-antibiotic era in the critically ill: the XDR problem.
    Paterson DL; Lipman J
    Crit Care Med; 2007 Jul; 35(7):1789-91. PubMed ID: 17581370
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of colistin in children.
    Tamma PD; Lee CK
    Pediatr Infect Dis J; 2009 Jun; 28(6):534-5. PubMed ID: 19483519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.